<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 323 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page322.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=323">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 323 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 323</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=323"><img src="../thumb/323.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>286 / 2020-04                                         Anti-Microbials / Endocrine System - 18.1.2 / 19 / 19.1.1
   Warnings and special precautions: Not proven to prev. HIV   inflam., decr. haematolog.indic., revers.neurolog.react., Oral preps:   Warnings and special precautions: Prolong. act.depend.on SC
   transmiss., opportunist.infects & other HIV complicat.still poss.,   skin rash, GI disturbs., headache, revers. neurolog.reacts., fatig.  inj., rotate inj.sites, IV admin. could result in sev. hypoglycaem., do
   monit.haematolog. paramet., discont.use if pancreat.suspect.,   Warnings and special precautions: Ren. impairm., adeq.hydrat.,   not dil/mix. with other insul., see lit.regard.change over from oth-
   ren./ hepat.funct.impairm., pts.with known risk facts.for liv.dis.,   pass.in breast milk., elderly.  er insulin(s), metabol.monit.recomm.dur. changeover & init.wks.
   discont.in pts.develop.lab.find.suggest. lact. acidos./hepatotox.,   Drug interactions: Probenecid incr.acyclovir mean half life.  thereaft., pres.of insul. antibod. may req.dos.adjustm., where hy-
   monit.liv.funct.in pts.with pre-exist.liv.dysfunct., pts.with hepato-  poglycaem. episod.of clinic.signific., circumst. where warn.sympts.
   megaly/ hepatit/other risk facts.for liv.dis./hepat.steatos., safety   of hypoglycaem.diminish., pt. to take precaut.avoid.hypoglycaem.if
   & effic.not est.co-infect.with hepatit.B pts., monit.hepat.funct.for   driving, ren./ hepat.impairm., elderly, risk of oed./HF with concom.
   sev.mnths.aft.discont.in pts. co-infect.with heaptit.B, pts.co-infect. 19   ENDOCRINE SYSTEM  thiazolidinediones esp.in pts.with underlying card.dis.
   with hepatit. C & treat.with alpha interferon & ribavarin, discont.   Drug interactions: Oral antidiabet.agents/ACE-inhibit./disopyra-
   if hyperlactataem.& metabol./lact.acidos./ progress.hepatomeg./  mide/fibrates/fluoxetine/ MAOI/, pentoxifylline/ propoxyphene/
   rapid.elev.aminotransferas. lev.develops., investig.poss.mitochondr.   19.1   Anti-diabetic agents  salicylates/ somatostat.analog.& sulfonamide antibiot.may enhanc.
   dysfunct. in childr.expos.in utero to nucleoside & nucleot. analogues   bld.gluc.low.eff., corticoster./niacin/ /danazol/diazoxide/diuret./
   show.relev.S&S., signs of fat redistribut., meas.fast ser.& bld.gluc.,   glucagon/isoniazid/ oestrog./progestog./phenothiaz.deriv./ somat-
   manage lipid disords as clinic.appropr., eval.any inflamm. sympts.&
   instit.treatm., not recomm.in hepatit.C due to incr.anaem.risk., pts.to  19.1.1  Insulins  ropin/ sympathomimet./protease inhibits./ atypic.antipsychot.meds
                                                              & thyroid hormon.may reduc.bld.gluc.low.eff., ß-block./clonid/Li &
   seek med.advice if experienc.joint pain/aches/stiffn./movem.diffic.  alcohol may either potent.or weak.bld.gluc.low. eff., pentamid.may
   as osteonecros.poss., cons.benef./risk dur.pregn., HIV transmiss.to   ACTRAPHANE HM (ge), Novo Nordisk  cause hypoglycaem.follow.by hyperglycaem., signs of hypoglycaem.
   inft.dur.pregn.still poss.despite ther., in situat.where discont.of one   Biphasic biosynthetic human insulin susp.compris. 30% soluble in-  reduc./ absent in pts.taking sympatholyt.
   of the act./dos. adjustm. necess.use separ.preps., elderly, consid.  sulin & 70% isophane insulin.  HUMALOG, Eli Lilly
   effs.of separ.agents dur.combin.ther., unclear if adv.effs.are drug   Indications: Diabet.mellit.  Insulin lispro of recombin.DNA origin.
   relat./part of underly. dis.process.  (S3) INJ. W/21.1/287. 100 u/ml.  Indications: Diab.mellit.req.insulin for norm.gluc. homeostas.
   Drug interactions: Trimethoprim incr.lamivudine plasma lev., in-  733512-003: 1x10 ml vial, R322,45  maint., init.stabilisat.of diab.mellit.
   tracell.phosphorylat.of concom. zalcitabine pos.inibit., zidovudine   714977-001: 5x3 ml, FlexPen, R632,97  (S3) SOL.FOR INJ. 29/21.1/0785. 100 IU/ml.
   metabol.poss.alt. by meds.direct.inhibit.hepat.microsom.metabol./   Dosage: Individ. Requirem.usuall.betw.0,3 to 1,0 IU/kg/day.  819468-002: 10 ml vial, R300,69
   competit.glucuronidat. inhibit., phenytoin bld.lev. alt., poss.incr.toxic.  Ref.to prod.lit.for var.device use  862355-001: 5x3 ml cartridge (use with pen), R435,87
   risk with potent nephrotox./ myelosuppres.meds., probenecid incr.  Contraindications: Hypoglycaem.  706760-001: 5x3 ml kwikpen (dispos.& prefill.) R458,81
   zidovudine mean half-life & area und.plasma conc.curve., rifampic-  Side effects: Hypoglycaem., anaphylact.reacts., urticar., rash,   Dosage: SC/IV Admin.15 mins.bef./at mealtimes/ soon aft.
   in decr.zidovudine AUC, ribavirin/ stavudine is antagonist.in vitro  diabet.retinopathy, periph. neuropathy, lipodystrophy, loc.reacts.,   meals. Indiv.
                                refract. disords., oed.
   ZOVIRAX, GSK [P/S]           Warnings and special precautions: Congest.HF report. piogl-  (S3) SOL.FOR INJ, 50/21.1/0680. 200 units/ml
   Acyclovir                    itazone & insul.combinat., discont. pioglitazone if deteriorat.in card.  723920-001: 5x3 ml Kwikpen, R917,63
   Indications: Treatm.& prophylax.of H.simplex infects.in immuno-  sympts.occur, usual hypoglycaem.warn.signs poss.chang. tfd.pts. to   Dosage: Reserv.for pts.req.dly.dos.of more than 20 units of rap-
   comprom.pts., treatm.of Varicella infects.in immunocomprom.pts.   new /type brand insul.und.strict med.supervis., poss. hyperglycaem./  id-act.insul.
   (in shingles only if lesions not older than 72 hrs), H.simplex infects.  diab.ketoacidos.with inadeq. dos./treatm.discont., nev.for IV use   SC admin.15 mins.bef./at mealtimes/ soon aft. meals. Indiv.
   in neonate, H.simplex encephalit., prevent.of reactivat. of cytomeg-  or use in insul. infus.pumps, sev.hypoglycaem.may lead to uncon-  (S3) MIX 25 SUSP.FOR INJ, 33/21.1/0073. 100 IU/ml
   alovirus infect.in sero-positiv. pts.aft.bone marrow transplantat.  sciousn. &/ convuls.poss.lead.to perm.brain funct. impairm.& death,   25% insulin lispro & 75% insulin lispro protamine suspension (NPL).
   (S4) IV INFUS, [P/S] Q/20.2.8/164.  time zone travel as meal times may alt., infects.& fev.condit., ren./   853437-009: 10 ml vial, R340,38
   779415-019: 250 mg, 5, R2 408,58  hepat. impairm., tempor.worsen.of diabet.retinopathy with insul.  861782-003: 5x3 ml cartridge (use with pen), R516,56
   Dosage: Admin.by slow IV infus.over 1 hr. Durat. of treatm norm 5   ther.intensificat.& abrupt movem.in glycaem.control.  706761-001: 5x3 ml Kwikpen (dispos.& prefill.) R612,93
   days adjust.to pt.condit.& ther. respons.  Drug interactions: Oral hypoglycaem.agents/ MAOI/non-select.   Dosage: SC only. Admin.close to mealtimes/soon aft.meals. Indiv.
   H.encephalit.& neonat.H.simplex infects: Usual. 10 days bear.  ß-block./ACE inhibit/salicylates & alcoh.poss.reduc.insul.requirem.,   (S3) MIX 50 SUSP.FOR INJ, 33/21.1/0074. 100 IU/ml
   in mind pts.condit.& respons.  OC’s/thiaz./ glucocortic./ thyroid hormones/sympathomimet./   50% insulin lispro & 50% insulin lispro protamine suspension (NPL).
   H.simplex infect: Immunocomprom: Adults: 5 mg/kg 8 hrly.   growth hormone & danazol may incr.insulin requirem., ß-block.poss.  705074-001: 5x3 ml cartridge (use with Pen), R516,56
          2
   Childr: 250 mg/m  8 hrly.    mask hypoglycaem., ocreotide may decr.& incr.insul.requirem., alcoh.   706762-001: 5x3 ml Kwikpen (dispos.& prefill.) R612,94
   Varicella-zoster: Immunocomprom.(norm. ren. funct): Adults:   intens.& prolongs hypoglycaem.eff.  Dosage: SC only. Admin.close to mealtimes/soon aft.meals. Indiv.
                 2
   10 mg/kg 8 hrly. Childr: 500 mg/m  8 hrly.                 Contraindications: Hypoglycaem., IV admin.of Mix 25 & Mix 50.
   H.simplex encephalit: Norm./ immunocomprom: (norm.ren.  APIDRA, Sanofi-Aventis  Side effects: Lipodystrophy, oed., insul.resist., hypoglycaem., hy-
   funct): Adults: 10 mg/kg 8 hrly. Childr: Norm.with norm.ren. funct:   Insulin glulisine  persens., system.allergy
   500 mg/m  8 hrly.            Indications: Diab.mellit.where insulin treatm. reqd.  Warnings and special precautions: Quick act. & short.durat.,
       2
   Neonates: H.simplex infects: 10 mg/kg 8 hrly.  (S3) SOL FOR INJ, A38/21.1/0506. 3,5 mg/ml correspond.to   transf.from other insulins, warn. sympts. of hypoglycaem.poss.less
   CMV: Adults & childr.over 2 yrs: 500 mg/m  IV 3xdly. 8 hrly.begin.   100 IU human insul.  pronounc./diff., imp. ren./hepat.funct., adj.dos.dur.illn./emot. disturb.
                      2
   5 days bef.op up to 30 days aft.transplant.  706040-001: 1x10 ml vial, R370,38  /incr.physic.activ., safety & effic.of Mix 25 & 50 not est. in pregn./
   (S4) DISPERS.TABS, [P/S] 29/20.2.8/0452   706039-001: 5X3 ml cartridge, R413,57  pts.und.18 yrs., diet chang., transfer of pts.to other types/brands of
   Indications: Init.& recurr. H.simplex.infects.of skin & mu-  709861-001: 5x3 ml solostar, R521,63  insulin und. strict medic.supervis., may be combin.with LA insul/ oral
   cous membr., init.& recurr.genit. H.simplex., suppress.of recurr.  Dosage: Admin.15 mins.bef./immed.aft a meal. Only for SC admin.  sulphonylurea on drs.advice, pregn., nurs. mothers., use as part of
                                                          st
   genit.H.simplex in immunocompet.pts., prophylax.of H.simplex.   by inj./contin.pump infus. Keep at room temp.x1-2 hrs.bef.1  time   regim.that incl.a LA insul. in treat.Type 1 diabet., concom. thiazoli-
   infects.in immunocomprom.pts., treatm.of H.zoster. infects.if le-  use. May mix with NPH human insul.when Apidra should be drawn   dinediones assoc.with incr.risk of oed.& HF esp. in pts.with underly.
   sions not older than 72 hrs., treatm.of Varicella zoster within 24   into syringe first & to be admin.immed. aft.mix.   card.dis., do not transf. cont. of pre-fill.del.device to syringe., do not
   hrs.of typic.chickenpox rash, reduct.of mortality & risk of herpes   Indiv.dos.accord.to pts.needs.as determin.by physic. Use in regimen   mix 200 units/ml Kwikpen with any other insul.
   vir. infects. in cert.sev.immunocomprom.pts.(eg. advanc. HIV dis.  that includes long.act. insul./bas.insul.analogue.  Interactions: Insul.requirem.incr.by meds.with hyperglycaem.activ.
   or follow.bone-marr.transplantat.)  Contraindications: Safety in pregn.& lactat.not est., safety &   eg.OC’s/corticoster./thyroid replacem.ther., insul.requirem.decr.in
   833703-005: 200 mg, 25, R595,12  effic.in paed.pts.not est., mix.of any other insulins in cartridge, IV   pres.of oral anti-diabet.agents/salicylates/sulpha antibiot./ MAOI/
   (S4) SUSP,[P/S]27/20.2.8/0236. 200 mg/5 ml.  admin.of mixt., mix with diluents/any other insul.when used with   ACE inhibit./angiotens.II recept.block., ß-block. may mask sympts.
                                                              of insul.-induc. hypoglycaem.
                                insul.infus.pump.
   789313-006: 125 ml, R885,89
   Dosage: Adults: Tabs.may be dispers.in a min.of 50 ml water or   Side effects: Hypoglycaem., inj.site reacts., loc. hypersens.re-  HUMULIN N, Eli Lilly
                                acts., lipodystrophy if inj. sites not rotat., gen.system.hypersens.
   swallow.whole with water.                                  Biosynth.isophane human insulin (rDNA origin).
   Init.& recurr.skin & mucous membr.H. simplex. infects:   reacts. potent.life threat.  Indications: Diab.mellit.
                                Special precautions: Monit.poss.hyper-/hypoglycaem., elderly,
   200 mg 5x/day at approx.4 hrly. interv.ommit.night time dos.x5 days.  (S3) SUSP.FOR INJ, R/21.1/0001. 100 IU/ml
   Sev.immunocompromis.pts./pts.with imp.gut absorpt: Dos.may   ren./hepat.impairm., short durat. of act.req.long.act.insul.to main-  733458-009: 10 ml vial, R338,83
                                tain control, transf. pts to other types/brands, poss. concom. oral
   be doubl.to 400 mg or alternat. IV therapy.                863556-019: 5x3 ml cartridge (use with Humapen), R499,24
   Suppress.of recurr.H.simplex infects.in immunocompetent:   antidiabet.dos.adjustm., concom. illn./infect.  853453-004: 5x3 ml dispos.pens, R499,24
                                Drug interactions: Bld.gluc.lower.eff.enhanc.by oral antidiabet.
   Adults: 200 mg 4xdly, 6 hrly/ 400 mg 2xdly 12 hrly. Titrat.down to   agents./ACE inhibit./ disopyramide/ fibrates/fluoxetine/MAOI/ pen-  Dosage: Admin.SC/IM only, Indiv.
   200 mg 8-12 hrly may prove effect. Interrupt at 6-12 mnthly. interv.   toxifylline/ propoxyphene/salicylates & sulfonamide antibiot., bld.  HUMULIN R
   to observe any poss.changes.  gluc.low.eff.reduc.by corticoster./ danazol/diazoxide/diuret./gluca-  Biosynthetic human insulin, regular (rDNA origin).
   H.simplex prophylax in immunocomprom. Adults: 200 mg   gon/ isoniazid/oestrog.& progestog/phenothiaz. derivat./ somatrop./  Indications: Diab.mellit.
   4xdly 6 hrly.                sympathomimet/thyroid hormones/protease-inhibit & atypic.antip-  (S3) SOL.FOR INJ, R/21.1/0002. 100 IU/ml,
   Sev.compromis.pts./pts.with imp.gut absorpt: Dos.may be    733431-003: 10 ml vial, R299,32
   doubl.to 400 mg.or IV therapy consid., durat.of therapy determin.  sychot. meds., beta-block./clonidine/Li salts & alcoh. either potent./  863564-003: 5x3 ml cartridge (use with Humapen), R477,40
                                weak.bld.gluc.low.eff., pentamidine poss.caus.hypoglycaem.follow.
   by period at risk.                                         Dosage: Admin. SC/IM/IV, indiv.
   H.zoster & Varicella-zoster infects: Adults: 800 mg 5xdly at   by hyperglycaem., adrenerg.counter-regulat.signs reduc. or absent   HUMULIN 30/70
                                und.sympatholyt.influence.
   approx. 4 hrly interv., omit night-time dos.x7 days.       30% biosynthetic reg.human insulin, 70% biosynthetic isophane
   Varicella-zoster infects. in adolescents (12-18 yrs): 800 mg   BASAGLAR, Eli Lilly  human insulin (rDNA origin).
   4xdly x5 days.               Insulin glargine, correspond.to 100 U human insulin/ml.  Indications: Diab.mellit.
   Sev.immunocomprom.pts: 800 mg 4xdly.at 6 hrly.interv. In bone   Indications: Diab.mellit.in adults, adolesc.& childr. ≥ 6 yrs where   (S3) SUSP.FOR INJ, W/21.1/397. 100 IU/ml
   marr.recipients this to be preced.by up to 1 mnths.IV therapy of   insulin treatm.reqd.as a basal/ part of basal-bolus regim.  783811-004: 1x10 ml vial, R338,82
   500 mg/m  3xdly.             (S3) SOL.FOR INJ, 49/21.1/0708. 100 U/ml  863572-006: 5x3 ml cartridge (use with Humapen), R499,24
       2
   Childr: Treatm./prophylax.of H.simplex infects.in immune   722456-001, 5x3 ml cartridges, R515,20  704456-001: 5x3 ml dispos.pen, R499,24
   comprom.childr: 2 yrs.& older: Adults dos. Below 2 yrs: ½ adult   722454-001, 5x3 ml pre-fill.pen, R603,60  Dosage: Admin. SC/IM only. Indiv., to improv. glycaem. contr.dos.
   dos. Oral admin.in childr. und. 2 yrs. has not been fully studied.  Dosage: Indiv.  may need to be split in some pts.: admin.one-half to two-thirds
   Varicella: 20 mg/kg bm (not exceed. 800 mg) 4xdly commenc.within   Contraindications: Safety & effic.not est.in childr.&lt; 6 yrs old, dia-  of dly.dos.in morn. with remaind.of dos.bef.supper/later in even.
   24 hrs.of rash & contin. x5 days.  bet.ketoacidos., no info on use in pregn.& lactat.  Contraindications: Hypoglycaem., IV use except Humulin R.
   Contraindications: Valacyclovir hypersens., safety in pregn.not   Side effects: Hypoglycaem., poss.vis.impairm. with mark.change   Side effects: Lipodystrophy, insulin resist., hypersens. reacts., hy-
   est., do not give IV presentat.as IV bolus inj.  in glycaem.contr., lipohypertrophy/ lipoatrophy, loc.reacts., al-  poglycaem., system.allergy, oed.
   Side effects: IV infus: Incr.in bld.urea & creatin. lev.relat.to state   lerg. reacts., insul.antibod.product., rarely sod.retent.& oed., my-  Warnings and special precautions: Transf. from/to other insu-
   of hydrat., ren.impairm., N&V, incr.in liv.relat.enzym., rash, fev., loc.  algia, dysgeus.  lins, requirem.poss.incr.dur.illn./ emot. disturbs., insulin requirem.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page322.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page318.html">318</a>&nbsp;&nbsp;&nbsp;<a href="page319.html">319</a>&nbsp;&nbsp;&nbsp;<a href="page320.html">320</a>&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>
             </td>
             <td width="35%"><a href="page324.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page324.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
